| For: | Yanai H, Masui Y, Yoshikawa R, Kunimatsu J, Kaneko H. Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes. World J Diabetes 2010; 1(3): 99-100 [PMID: 21537433 DOI: 10.4239/wjd.v1.i3.99] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v1/i3/99.htm |
| Number | Citing Articles |
| 1 |
Yoshihide Fujigaki. Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels. Medical Science Monitor 2014; 20 doi: 10.12659/MSM.889872
|
| 2 |
Anna Mehlich, Marek Bolanowski, Dawid Mehlich, Przemysław Witek. Medical treatment of Cushing’s disease with concurrent diabetes mellitus. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1174119
|
| 3 |
Satoshi Ito, Hiroshi Ogishima, Yuya Kondo, Makoto Sugihara, Taichi Hayashi, Yusuke Chino, Daisuke Goto, Isao Matsumoto, Takayuki Sumida. Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases. Modern Rheumatology 2013; doi: 10.1007/s10165-013-0834-y
|
| 4 |
Mattia Barbot, Filippo Ceccato, Carla Scaroni. Diabetes Mellitus Secondary to Cushing’s Disease. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00284
|
| 5 |
Al’bert Yu. Selimov, Lyudmila N. Eliseeva, Valeriya P. Kurinnaya, Sergei P. Oranskii. GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION. Kuban Scientific Medical Bulletin 2019; 26(1) doi: 10.25207/1608-6228-2019-26-1-209-218
|
| 6 |
Ս.Ա. Մաղաքյան. Գլյուկոկորտիկոիդ-ասոցացված հիպերգլիկեմիայի կառավարումը օնկոլոգիական հիվանդների շրջանում. Medical Science of Armenia 2026; 66(3) doi: 10.54503/0514-7484-2026-66.3-39
|
| 7 |
Takayuki Katsuyama, Ken-Ei Sada, Sayaka Namba, Haruki Watanabe, Eri Katsuyama, Toshio Yamanari, Jun Wada, Hirofumi Makino. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Research and Clinical Practice 2015; 108(2) doi: 10.1016/j.diabres.2015.02.010
|
| 8 |
Parag Shah, Sanjay Kalra, Yogesh Yadav, Nilakshi Deka, Tejal Lathia, Jubbin Jagan Jacob, Sunil Kumar Kota, Saptarshi Bhattacharya, Sharvil S Gadve, KAV Subramanium, Joe George, Vageesh Iyer, Sujit Chandratreya, Pankaj Kumar Aggrawal, Shailendra Kumar Singh, Ameya Joshi, Chitra Selvan, Gagan Priya, Atul Dhingra, Sambit Das. Management of Glucocorticoid-Induced Hyperglycemia. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; doi: 10.2147/DMSO.S330253
|
| 9 |
P. Hyma, K. Abbulu. Formulation and characterisation of self-microemulsifying drug delivery system of pioglitazone. Biomedicine & Preventive Nutrition 2013; 3(4) doi: 10.1016/j.bionut.2013.09.005
|
| 10 |
Sunghwan Suh, Mi Kyoung Park. Management of Steroid-induced Hyperglycemia. The Journal of Korean Diabetes 2016; 17(3) doi: 10.4093/jkd.2016.17.3.174
|
| 11 |
Aleksandra Ostrowska-Czyżewska, Wojciech Zgliczyński, Lucyna Bednarek-Papierska, Beata Mrozikiewicz-Rakowska. Is It Time for a New Algorithm for the Pharmacotherapy of Steroid-Induced Diabetes?. Journal of Clinical Medicine 2024; 13(19) doi: 10.3390/jcm13195801
|
| 12 |
Tomohiro Matsuhashi, Motoaki Sano, Keiichi Fukuda, Shun Kohsaka, Yoshihiko Suzuki. Sitagliptin counteracts seasonal fluctuation of glycemic control. World Journal of Diabetes 2012; 3(6): 118-122 doi: 10.4239/wjd.v3.i6.118
|
| 13 |
Jung Wan Park, Mi Kyung Kwak, Samel Park, Nam Hun Heo, Eun Young Lee. Association of Dipeptidyl Peptidase-4 Inhibitor Use with COVID-19 Mortality in Diabetic Patients: A Nationwide Cohort Study in Korea. Journal of Clinical Medicine 2025; 14(16) doi: 10.3390/jcm14165815
|
| 14 |
Sarah Noetzlin, Gautier Breville, Jörg D. Seebach, Giacomo Gastaldi. Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach. Swiss Medical Weekly 2022; 152(0102) doi: 10.4414/SMW.2022.w30088
|
| 15 |
Resal Raj, Jasvinder Singh Bhatti, Sanjay Kumar Badada, Pramod W. Ramteke. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM). Diabetes/Metabolism Research and Reviews 2015; 31(7) doi: 10.1002/dmrr.2630
|
| 16 |
Sunghwan Suh, Mi Kyoung Park. Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem. Endocrinology and Metabolism 2017; 32(2) doi: 10.3803/EnM.2017.32.2.180
|